Clinical Trial Update: Evaluating the Effects of Electroacupuncture and Rosiglitazone Combined Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating the combined therapy of electroacupuncture and rosiglitazone in patients with type 2 diabetes mellitus with features …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type Diabetes Mellitus with Features of Insulin Resistance

Drugs mentioned

• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: China Medical University Hospital | Conditions: Type 2 Diabetes Mellitus With Features of Insulin Resistance | Phase 2 | Status: COMPLETED